Logo image
The molecular basis of mouse adaptation by human enterovirus 71
Journal article   Open access   Peer reviewed

The molecular basis of mouse adaptation by human enterovirus 71

B.H. Chua, P. Phuektes, S.A. Sanders, P.K. Nicholls and P.C. McMinn
Journal of General Virology, Vol.89(7), pp.1622-1632
2008
pdf
molecular_basis_of_mouse_adaptation.pdfDownloadView
Author’s Version Open Access
url
Free to Read *No subscription requiredView

Abstract

A mouse-adapted strain of human enterovirus 71 (HEV71) was selected by serial passage of a HEV71 clinical isolate (HEV71-26M) in Chinese hamster ovary (CHO) cells (CHO-26M) and in newborn BALB/c mice (MP-26M). Despite improved growth in CHO cells, CHO-26M did not show increased vilrulence in newborn BALB/c mice compared with HEV71-26M. By contrast, infection of newborn mice with MP-26M resulted in severe disease of high mortality. Skeletal muscle was the primary site of replication in mice for both viruses. However, MP-26M infection induced severe necrotizing myositis, whereas CHO-26M infection caused only mild inflammation. MP-26M was also isolated from whole blood, heart, liver, spleen and brain of infected mice. CHO-26M harboured a single mutation within the open reading frame (ORF), resulting in an amino acid substitution of K149-I in the VP2 capsid protein; two further ORF mutations that resulted in amino acid substitutions were identified in MP-26M, located within the VP1 capsid protein (G145-E) and the 2C protein (K216-R). Infectious cDNA clone-derived mutant virus populations containing the mutations identified in CHO-26M and MP-26M were generated in order to study the molecular basis of CHO cell and mouse adaptation. The VP2 (K149-I) change was responsible only for improved growth in CHO cells and did not lead to increased virulence in mice. Of the two amino acid substitutions identified in MP-26M, the VP1 (G145-E) mutation alone was sufficient to increase virulence in mice to the level observed in MP-26M-infected mice.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

378 File views/ downloads
57 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.104 Virology - General
1.104.901 Enterovirus Research
Web Of Science research areas
Biotechnology & Applied Microbiology
Virology
ESI research areas
Microbiology
Logo image